​

Exact Sciences (EXAS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EXAS Stock Forecast

Exact Sciences (EXAS) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $103.18, with a high of $105.00 and a low of $85.00. This represents a -0.21% decline from the last price of $103.40.

$40 $53 $66 $79 $92 $105 High: $105 Avg: $103.18 Low: $85 Last Closed Price: $103.4

EXAS Stock Rating

Exact Sciences stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 22 Buy (53.66%), 17 Hold (41.46%), 2 Sell (4.88%), and 0 Strong Sell (0.00%).

Buy
Total 41 0 2 17 22 Strong Sell Sell Hold Buy Strong Buy

EXAS Price Target Upside V Benchmarks

TypeNameUpside
StockExact Sciences-0.21%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks30.02%

Price Target Trends

1M3M12M
# Anlaysts-220
Avg Price Target-$105.00$87.85
Last Closing Price$103.40$103.40$103.40
Upside/Downside-1.55%-15.04%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 261120--22
Feb, 261219--22
Jan, 261318--22
Dec, 25-318--21
Nov, 253172--22
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 20, 2026Mizuho Securities$105.00$102.432.51%1.55%
Jan 05, 2026Evercore ISI$105.00$101.743.20%1.55%
Nov 28, 2025Stifel Nicolaus$105.00$101.293.66%1.55%
Nov 25, 2025Canaccord Genuity$105.00$101.013.95%1.55%
Nov 24, 2025David WestenbergPiper Sandler$105.00$101.003.96%1.55%
Nov 24, 2025Tycho PetersonJefferies$105.00$100.904.06%1.55%
Nov 21, 2025Bill BonelloCraig-Hallum$105.00$100.674.30%1.55%
Nov 20, 2025Barclays$105.00$100.674.30%1.55%
Nov 20, 2025Wells Fargo$105.00$86.1821.84%1.55%
Nov 20, 2025Catherine Ramsey SchulteRobert W. Baird$105.00$101.343.61%1.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 25, 2025Cowen & Co.BuyHolddowngrade
Nov 24, 2025Piper SandlerOverweightNeutraldowngrade
Nov 24, 2025BenchmarkBuyHolddowngrade
Nov 24, 2025JefferiesBuyHolddowngrade
Nov 21, 2025Craig-HallumBuyHolddowngrade
Nov 20, 2025William BlairOutperformMarket Performdowngrade
Nov 20, 2025Wolfe ResearchPeer Performdowngrade
Nov 20, 2025BTIGBuyNeutraldowngrade
Nov 20, 2025CitigroupBuyNeutraldowngrade
Nov 20, 2025GuggenheimBuyNeutraldowngrade

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.48$-3.54$-1.13$-5.59$-1.10---
Avg Forecast$-3.11$-3.63$-1.28$-1.16$-0.31$0.58$1.02$1.29
High Forecast$-3.07$-3.55$-1.25$-1.10$0.10$1.48$2.01$1.33
Low Forecast$-3.19$-3.70$-1.37$-1.23$-1.18$-0.70$-0.11$1.26
Surprise %11.90%-2.48%-11.72%381.90%254.84%---

Revenue Forecast

$2B $2B $3B $3B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.77B$2.08B$2.50B$2.76B$3.25B---
Avg Forecast$1.74B$2.05B$2.49B$2.75B$3.06B$3.44B$3.79B$4.07B
High Forecast$1.78B$2.09B$2.51B$2.76B$3.12B$3.44B$3.81B$4.17B
Low Forecast$1.72B$2.02B$2.45B$2.74B$3.03B$3.44B$3.77B$4.00B
Surprise %1.38%1.48%0.37%0.44%6.25%---

Net Income Forecast

$-2B $-1B $-700M $-300M $100M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-595.63M$-623.51M$-204.15M$-1.03B$-207.95M---
Avg Forecast$-483.64M$-726.05M$-204.15M$-214.04M$-92.28M$66.66M$183.02M$232.39M
High Forecast$-386.91M$-580.84M$-163.32M$-198.19M$18.02M$266.73M$361.87M$239.16M
Low Forecast$-580.37M$-871.25M$-244.98M$-220.79M$-212.48M$-125.70M$-19.61M$226.88M
Surprise %23.15%-14.12%-380.69%125.34%---

EXAS Forecast FAQ

Is Exact Sciences stock a buy?

Exact Sciences stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 22 Buy, 17 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Exact Sciences is a favorable investment for most analysts.

What is Exact Sciences's price target?

Exact Sciences's price target, set by 41 Wall Street analysts, averages $103.18 over the next 12 months. The price target range spans from $85 at the low end to $105 at the high end, suggesting a potential -0.21% change from the previous closing price of $103.4.

How does Exact Sciences stock forecast compare to its benchmarks?

Exact Sciences's stock forecast shows a -0.21% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (30.02%).

What is the breakdown of analyst ratings for Exact Sciences over the past three months?

  • March 2026: 4.55% Strong Buy, 4.55% Buy, 90.91% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 4.55% Strong Buy, 9.09% Buy, 86.36% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 4.55% Strong Buy, 13.64% Buy, 81.82% Hold, 0% Sell, 0% Strong Sell.

What is Exact Sciences’s EPS forecast?

Exact Sciences's average annual EPS forecast for its fiscal year ending in December 2026 is $0.58, marking a -152.73% decrease from the reported $-1.1 in 2025. Estimates for the following years are $1.02 in 2027, and $1.29 in 2028.

What is Exact Sciences’s revenue forecast?

Exact Sciences's average annual revenue forecast for its fiscal year ending in December 2026 is $3.44B, reflecting a 5.87% increase from the reported $3.25B in 2025. The forecast for 2027 is $3.79B, and $4.07B for 2028.

What is Exact Sciences’s net income forecast?

Exact Sciences's net income forecast for the fiscal year ending in December 2026 stands at $66.66M, representing a -132.05% decrease from the reported $-208M in 2025. Projections indicate $183.02M in 2027, and $232.39M in 2028.